Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

Clinical trial NCT07518329 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07518329
Sponsor: Arovella Therapeutics Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma (NHL)Leukaemia

Start date: 2026-08-20
Primary completion: 2030-03-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.